Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Experimental Hematology|September 20, 2006
Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantationMiquel Granell, Alvaro Urbano-Ispizua, Belén Suarez, et al.
Haematologica|March 4, 2017
Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definitionMiquel Granell, Xavier Calvo, Antoni Garcia-Guiñón, et al.
Blood|March 2, 2006
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemiaMariano Monzo, Salut Brunet, Alvaro Urbano-Ispizua, et al.
European Journal of Haematology|February 6, 2019
Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myelomaRaquel Jiménez-Segura, Miquel Granell, Mercè Gironella, et al.
Blood|September 6, 2008
Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantationMiquel Granell, Alvaro Urbano-Ispizua, Aina Pons, et al.
Bone Marrow Transplantation|August 18, 2021
Predictors of return to work after autologous stem cell transplantation in patients with multiple myelomaMiquel Granell, Alicia Senín, Anna Barata, et al.
Leukemia & Lymphoma|April 5, 2017
FcγRIIb expression in early stage chronic lymphocytic leukemiaRosa Bosch, Alba Mora, Eva Puy Vicente, et al.
Haematologica|November 8, 2011
Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable diseaseLaura Rosiñol, Ramón García-Sanz, Juan José Lahuerta, et al.
Haematologica|June 13, 2015
Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trialRamón García-Sanz, Albert Oriol, María J Moreno, et al.
Annals of Hematology|February 15, 2025
Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myelomaAntoni Garcia-Guiñon, Paola Andrea Charry, María Jimenez, et al.
Pageof 4